American Century Companies’s Utah Medical Products UTMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$450K Sell
7,253
-47
-0.6% -$2.96K ﹤0.01% 2544
2025
Q4
$409K Sell
7,300
-878
-11% -$50.9K ﹤0.01% 2560
2025
Q3
$515K Sell
8,178
-577
-7% -$34.1K ﹤0.01% 2502
2025
Q2
$498K Buy
8,755
+65
+0.7% +$3.54K ﹤0.01% 2526
2025
Q1
$487K Buy
8,690
+555
+7% +$33.3K ﹤0.01% 2519
2024
Q4
$500K Buy
8,135
+643
+9% +$41.6K ﹤0.01% 2505
2024
Q3
$501K Sell
7,492
-4,429
-37% -$301K ﹤0.01% 2476
2024
Q2
$796K Buy
11,921
+1,830
+18% +$125K ﹤0.01% 2264
2024
Q1
$718K Buy
10,091
+1,694
+20% +$127K ﹤0.01% 2289
2023
Q4
$707K Buy
8,397
+2,427
+41% +$201K ﹤0.01% 2220
2023
Q3
$513K Buy
5,970
+995
+20% +$91.8K ﹤0.01% 2259
2023
Q2
$464K Buy
+4,975
New +$469K ﹤0.01% 2254
2017
Q4
Sell
-67,094
Closed -$4.93M 1373
2017
Q3
$4.93M Sell
67,094
-93,447
-58% -$6.72M 0.01% 854
2017
Q2
$11.6M Sell
160,541
-9,282
-5% -$611K 0.01% 638
2017
Q1
$10.6M Buy
169,823
+4,435
+3% +$279K 0.01% 655
2016
Q4
$12M Sell
165,388
-12,562
-7% -$817K 0.01% 627
2016
Q3
$10.6M Sell
177,950
-10,223
-5% -$650K 0.01% 669
2016
Q2
$11.9M Sell
188,173
-48,784
-21% -$3.15M 0.01% 624
2016
Q1
$14.8M Sell
236,957
-16,851
-7% -$994K 0.02% 567
2015
Q4
$14.9M Buy
253,808
+358
+0.1% +$20.3K 0.02% 556
2015
Q3
$13.7M Sell
253,450
-11,563
-4% -$631K 0.02% 581
2015
Q2
$15.8M Sell
265,013
-1,943
-0.7% -$109K 0.02% 601
2015
Q1
$16M Sell
266,956
-37,496
-12% -$2.2M 0.02% 592
2014
Q4
$18.3M Buy
304,452
+9,951
+3% +$551K 0.02% 567
2014
Q3
$14.4M Buy
294,501
+40,542
+16% +$2.06M 0.02% 594
2014
Q2
$13.1M Buy
253,959
+38,882
+18% +$2M 0.01% 643
2014
Q1
$12.4M Buy
215,077
+4,808
+2% +$262K 0.01% 653
2013
Q4
$12M Sell
210,269
-2,226
-1% -$122K 0.01% 663
2013
Q3
$12.6M Sell
212,495
-6,328
-3% -$345K 0.02% 631
2013
Q2
$11.9M Buy
+218,823
New +$10.3M 0.02% 627

Other funds holding UTMD

American Century Companies's UTMD Position: Q1 2026 in Review

American Century Companies reduced its Utah Medical Products (UTMD) stake by 0.64% in Q1 2026, selling an estimated $2.96K and leaving 7,253 shares worth $450K. The position accounts for ﹤0.01% of the portfolio, ranked #2544.

American Century Companies first reported a position in UTMD in Q2 2013 and has held it in 30 quarters since. The position peaked at $18.3M in Q4 2014. 119 funds tracked by Wall St. Rank hold UTMD as of Q1 2026.

  • American Century Companies held 7,253 shares of Utah Medical Products worth $450K as of Q1 2026.
  • American Century Companies sold 47 Utah Medical Products shares in Q1 2026, an estimated $2.96K.
  • Utah Medical Products made up ﹤0.01% of American Century Companies's portfolio in Q1 2026, its #2544 holding.
  • American Century Companies first reported a position in Utah Medical Products in Q2 2013 and has held it in 30 quarters since.
  • American Century Companies's Utah Medical Products position peaked at $18.3M in Q4 2014.
  • 119 funds tracked by Wall St. Rank held Utah Medical Products as of Q1 2026.

Based on American Century Companies's 13F filing for Q1 2026, filed 15 May 2026.